𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Growth Hormone-Releasing Hormone Antagonist MZ-4-71 Inhibits in vivo Proliferation of Caki-i Renal Adenocarcinoma

✍ Scribed by Andreas Jungwirth, Andrew V. Schally, Jacek Pinski, Kate Groot, Patricia Armatis and Gabor Halmos

Book ID
123640601
Publisher
National Academy of Sciences
Year
1997
Tongue
English
Weight
776 KB
Volume
94
Category
Article
ISSN
0027-8424

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of the growth of caki-I human
Inhibition of the growth of caki-I human renal adenocarcinoma in Vivo by luteinizing hormone-releasing hormone antagonist cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II
✍ Andreas Jungwirth; Andrew V. Schally; Gabor Halmos; Kate Groot; Karoly Szepeshaz 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views

## Background: Metastatic or recurrent renal cell carcinoma (rcc) is a therapeutic challenge because it is resistant to chemotherapy and external radiotherapy. no uniformly effective therapeutic agents are available for the management of patients with rcc. hormones and growth factors may play a rol

Inhibition of proliferation in human MNN
Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone : Effects on insulin-like growth factor II
✍ Ryszard Braczkowski; Andrew V. Schally; Artur Plonowski; Jozsef L. Varga; Kate G 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB 👁 2 views

## Abstract ## BACKGROUND Antagonists of growth hormone‐releasing hormone (GH‐RH) can inhibit the proliferation of various tumors either indirectly through the suppression of the pituitary growth hormone/hepatic insulin‐like growth factor I (__IGF‐I__) axis and the lowering of serum __IGF‐I__ conc